Benjamin Edwards’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Other funds holding PRME
Benjamin Edwards's PRME Position: Q3 2026 in Review
Benjamin Edwards increased its Prime Medicine (PRME) stake by 3.3% in Q3 2026, buying an estimated $1.14K and bringing the position to 10,671 shares worth $32.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.
Benjamin Edwards first reported a position in PRME in Q4 2022 and has held it in 13 quarters since. The position peaked at $89.6K in Q3 2024. 125 funds tracked by Wall St. Rank hold PRME as of Q3 2026.
- Benjamin Edwards held 10,671 shares of Prime Medicine worth $32.6K as of Q3 2026.
- Benjamin Edwards bought 342 Prime Medicine shares in Q3 2026, an estimated $1.14K.
- Prime Medicine made up ﹤0.01% of Benjamin Edwards's portfolio in Q3 2026, its #1448 holding.
- Benjamin Edwards first reported a position in Prime Medicine in Q4 2022 and has held it in 13 quarters since.
- Benjamin Edwards's Prime Medicine position peaked at $89.6K in Q3 2024.
- 125 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.